The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Penem Drug Intermediates 4-AA Market Research Report 2024
Synopsis
4-AA, or 4-Acetoxyazetidinone, serves as a crucial intermediate in the synthesis of penem antibiotics. It plays a pivotal role in the production of these antibiotics by providing the core structure necessary for further chemical transformations. Widely used in pharmaceutical manufacturing, 4-AA is integral for developing effective treatments against a range of bacterial infections.
The global Penem Drug Intermediates 4-AA market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Penem Drug Intermediates 4-AA is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Penem Drug Intermediates 4-AA is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Penem Drug Intermediates 4-AA include Zhejiang Hisoar Pharmaceutical, Jiangxi Fushine Pharmaceutical, Joincare Pharmaceutical, Jincheng Pharmaceutical, Zhejiang Jiuzhou Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Penem Drug Intermediates 4-AA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Penem Drug Intermediates 4-AA.
The Penem Drug Intermediates 4-AA market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Penem Drug Intermediates 4-AA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Penem Drug Intermediates 4-AA manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Zhejiang Hisoar Pharmaceutical
Jiangxi Fushine Pharmaceutical
Joincare Pharmaceutical
Jincheng Pharmaceutical
Zhejiang Jiuzhou Pharmaceutical
Segment by Type
Purity≥98%
Other
Segment by Application
Imipenem
Meropenem
Ertapenem
Biapenem
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Penem Drug Intermediates 4-AA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Penem Drug Intermediates 4-AA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
4-AA, or 4-Acetoxyazetidinone, serves as a crucial intermediate in the synthesis of penem antibiotics. It plays a pivotal role in the production of these antibiotics by providing the core structure necessary for further chemical transformations. Widely used in pharmaceutical manufacturing, 4-AA is integral for developing effective treatments against a range of bacterial infections.
The global Penem Drug Intermediates 4-AA market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Penem Drug Intermediates 4-AA is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Penem Drug Intermediates 4-AA is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Penem Drug Intermediates 4-AA include Zhejiang Hisoar Pharmaceutical, Jiangxi Fushine Pharmaceutical, Joincare Pharmaceutical, Jincheng Pharmaceutical, Zhejiang Jiuzhou Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Penem Drug Intermediates 4-AA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Penem Drug Intermediates 4-AA.
The Penem Drug Intermediates 4-AA market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Penem Drug Intermediates 4-AA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Penem Drug Intermediates 4-AA manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Zhejiang Hisoar Pharmaceutical
Jiangxi Fushine Pharmaceutical
Joincare Pharmaceutical
Jincheng Pharmaceutical
Zhejiang Jiuzhou Pharmaceutical
Segment by Type
Purity≥98%
Other
Segment by Application
Imipenem
Meropenem
Ertapenem
Biapenem
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Penem Drug Intermediates 4-AA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Penem Drug Intermediates 4-AA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Penem Drug Intermediates 4-AA Market Overview
1.1 Product Definition
1.2 Penem Drug Intermediates 4-AA by Type
1.2.1 Global Penem Drug Intermediates 4-AA Market Value Comparison by Type (2024-2030)
1.2.2 Purity≥98%
1.2.3 Other
1.3 Penem Drug Intermediates 4-AA by Application
1.3.1 Global Penem Drug Intermediates 4-AA Market Value by Application (2024-2030)
1.3.2 Imipenem
1.3.3 Meropenem
1.3.4 Ertapenem
1.3.5 Biapenem
1.3.6 Other
1.4 Global Penem Drug Intermediates 4-AA Market Size Estimates and Forecasts
1.4.1 Global Penem Drug Intermediates 4-AA Revenue 2019-2030
1.4.2 Global Penem Drug Intermediates 4-AA Sales 2019-2030
1.4.3 Global Penem Drug Intermediates 4-AA Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Penem Drug Intermediates 4-AA Market Competition by Manufacturers
2.1 Global Penem Drug Intermediates 4-AA Sales Market Share by Manufacturers (2019-2024)
2.2 Global Penem Drug Intermediates 4-AA Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Penem Drug Intermediates 4-AA Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Penem Drug Intermediates 4-AA, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Penem Drug Intermediates 4-AA, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Penem Drug Intermediates 4-AA, Product Type & Application
2.7 Global Key Manufacturers of Penem Drug Intermediates 4-AA, Date of Enter into This Industry
2.8 Global Penem Drug Intermediates 4-AA Market Competitive Situation and Trends
2.8.1 Global Penem Drug Intermediates 4-AA Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Penem Drug Intermediates 4-AA Players Market Share by Revenue
2.8.3 Global Penem Drug Intermediates 4-AA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Penem Drug Intermediates 4-AA Market Scenario by Region
3.1 Global Penem Drug Intermediates 4-AA Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Penem Drug Intermediates 4-AA Sales by Region: 2019-2030
3.2.1 Global Penem Drug Intermediates 4-AA Sales by Region: 2019-2024
3.2.2 Global Penem Drug Intermediates 4-AA Sales by Region: 2025-2030
3.3 Global Penem Drug Intermediates 4-AA Revenue by Region: 2019-2030
3.3.1 Global Penem Drug Intermediates 4-AA Revenue by Region: 2019-2024
3.3.2 Global Penem Drug Intermediates 4-AA Revenue by Region: 2025-2030
3.4 North America Penem Drug Intermediates 4-AA Market Facts & Figures by Country
3.4.1 North America Penem Drug Intermediates 4-AA Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Penem Drug Intermediates 4-AA Sales by Country (2019-2030)
3.4.3 North America Penem Drug Intermediates 4-AA Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Penem Drug Intermediates 4-AA Market Facts & Figures by Country
3.5.1 Europe Penem Drug Intermediates 4-AA Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Penem Drug Intermediates 4-AA Sales by Country (2019-2030)
3.5.3 Europe Penem Drug Intermediates 4-AA Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Penem Drug Intermediates 4-AA Market Facts & Figures by Region
3.6.1 Asia Pacific Penem Drug Intermediates 4-AA Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Penem Drug Intermediates 4-AA Sales by Region (2019-2030)
3.6.3 Asia Pacific Penem Drug Intermediates 4-AA Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Penem Drug Intermediates 4-AA Market Facts & Figures by Country
3.7.1 Latin America Penem Drug Intermediates 4-AA Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Penem Drug Intermediates 4-AA Sales by Country (2019-2030)
3.7.3 Latin America Penem Drug Intermediates 4-AA Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Penem Drug Intermediates 4-AA Market Facts & Figures by Country
3.8.1 Middle East and Africa Penem Drug Intermediates 4-AA Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Penem Drug Intermediates 4-AA Sales by Country (2019-2030)
3.8.3 Middle East and Africa Penem Drug Intermediates 4-AA Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Penem Drug Intermediates 4-AA Sales by Type (2019-2030)
4.1.1 Global Penem Drug Intermediates 4-AA Sales by Type (2019-2024)
4.1.2 Global Penem Drug Intermediates 4-AA Sales by Type (2025-2030)
4.1.3 Global Penem Drug Intermediates 4-AA Sales Market Share by Type (2019-2030)
4.2 Global Penem Drug Intermediates 4-AA Revenue by Type (2019-2030)
4.2.1 Global Penem Drug Intermediates 4-AA Revenue by Type (2019-2024)
4.2.2 Global Penem Drug Intermediates 4-AA Revenue by Type (2025-2030)
4.2.3 Global Penem Drug Intermediates 4-AA Revenue Market Share by Type (2019-2030)
4.3 Global Penem Drug Intermediates 4-AA Price by Type (2019-2030)
5 Segment by Application
5.1 Global Penem Drug Intermediates 4-AA Sales by Application (2019-2030)
5.1.1 Global Penem Drug Intermediates 4-AA Sales by Application (2019-2024)
5.1.2 Global Penem Drug Intermediates 4-AA Sales by Application (2025-2030)
5.1.3 Global Penem Drug Intermediates 4-AA Sales Market Share by Application (2019-2030)
5.2 Global Penem Drug Intermediates 4-AA Revenue by Application (2019-2030)
5.2.1 Global Penem Drug Intermediates 4-AA Revenue by Application (2019-2024)
5.2.2 Global Penem Drug Intermediates 4-AA Revenue by Application (2025-2030)
5.2.3 Global Penem Drug Intermediates 4-AA Revenue Market Share by Application (2019-2030)
5.3 Global Penem Drug Intermediates 4-AA Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zhejiang Hisoar Pharmaceutical
6.1.1 Zhejiang Hisoar Pharmaceutical Company Information
6.1.2 Zhejiang Hisoar Pharmaceutical Description and Business Overview
6.1.3 Zhejiang Hisoar Pharmaceutical Penem Drug Intermediates 4-AA Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zhejiang Hisoar Pharmaceutical Penem Drug Intermediates 4-AA Product Portfolio
6.1.5 Zhejiang Hisoar Pharmaceutical Recent Developments/Updates
6.2 Jiangxi Fushine Pharmaceutical
6.2.1 Jiangxi Fushine Pharmaceutical Company Information
6.2.2 Jiangxi Fushine Pharmaceutical Description and Business Overview
6.2.3 Jiangxi Fushine Pharmaceutical Penem Drug Intermediates 4-AA Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jiangxi Fushine Pharmaceutical Penem Drug Intermediates 4-AA Product Portfolio
6.2.5 Jiangxi Fushine Pharmaceutical Recent Developments/Updates
6.3 Joincare Pharmaceutical
6.3.1 Joincare Pharmaceutical Company Information
6.3.2 Joincare Pharmaceutical Description and Business Overview
6.3.3 Joincare Pharmaceutical Penem Drug Intermediates 4-AA Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Joincare Pharmaceutical Penem Drug Intermediates 4-AA Product Portfolio
6.3.5 Joincare Pharmaceutical Recent Developments/Updates
6.4 Jincheng Pharmaceutical
6.4.1 Jincheng Pharmaceutical Company Information
6.4.2 Jincheng Pharmaceutical Description and Business Overview
6.4.3 Jincheng Pharmaceutical Penem Drug Intermediates 4-AA Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jincheng Pharmaceutical Penem Drug Intermediates 4-AA Product Portfolio
6.4.5 Jincheng Pharmaceutical Recent Developments/Updates
6.5 Zhejiang Jiuzhou Pharmaceutical
6.5.1 Zhejiang Jiuzhou Pharmaceutical Company Information
6.5.2 Zhejiang Jiuzhou Pharmaceutical Description and Business Overview
6.5.3 Zhejiang Jiuzhou Pharmaceutical Penem Drug Intermediates 4-AA Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhejiang Jiuzhou Pharmaceutical Penem Drug Intermediates 4-AA Product Portfolio
6.5.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Penem Drug Intermediates 4-AA Industry Chain Analysis
7.2 Penem Drug Intermediates 4-AA Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Penem Drug Intermediates 4-AA Production Mode & Process
7.4 Penem Drug Intermediates 4-AA Sales and Marketing
7.4.1 Penem Drug Intermediates 4-AA Sales Channels
7.4.2 Penem Drug Intermediates 4-AA Distributors
7.5 Penem Drug Intermediates 4-AA Customers
8 Penem Drug Intermediates 4-AA Market Dynamics
8.1 Penem Drug Intermediates 4-AA Industry Trends
8.2 Penem Drug Intermediates 4-AA Market Drivers
8.3 Penem Drug Intermediates 4-AA Market Challenges
8.4 Penem Drug Intermediates 4-AA Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Penem Drug Intermediates 4-AA Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Penem Drug Intermediates 4-AA Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Penem Drug Intermediates 4-AA Market Competitive Situation by Manufacturers in 2023
Table 4. Global Penem Drug Intermediates 4-AA Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Penem Drug Intermediates 4-AA Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Penem Drug Intermediates 4-AA Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Penem Drug Intermediates 4-AA Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Penem Drug Intermediates 4-AA Average Price (US$/Ton) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Penem Drug Intermediates 4-AA, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Penem Drug Intermediates 4-AA, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Penem Drug Intermediates 4-AA, Product Type & Application
Table 12. Global Key Manufacturers of Penem Drug Intermediates 4-AA, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Penem Drug Intermediates 4-AA by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Penem Drug Intermediates 4-AA as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Penem Drug Intermediates 4-AA Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Penem Drug Intermediates 4-AA Sales by Region (2019-2024) & (Tons)
Table 18. Global Penem Drug Intermediates 4-AA Sales Market Share by Region (2019-2024)
Table 19. Global Penem Drug Intermediates 4-AA Sales by Region (2025-2030) & (Tons)
Table 20. Global Penem Drug Intermediates 4-AA Sales Market Share by Region (2025-2030)
Table 21. Global Penem Drug Intermediates 4-AA Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Penem Drug Intermediates 4-AA Revenue Market Share by Region (2019-2024)
Table 23. Global Penem Drug Intermediates 4-AA Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Penem Drug Intermediates 4-AA Revenue Market Share by Region (2025-2030)
Table 25. North America Penem Drug Intermediates 4-AA Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Penem Drug Intermediates 4-AA Sales by Country (2019-2024) & (Tons)
Table 27. North America Penem Drug Intermediates 4-AA Sales by Country (2025-2030) & (Tons)
Table 28. North America Penem Drug Intermediates 4-AA Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Penem Drug Intermediates 4-AA Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Penem Drug Intermediates 4-AA Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Penem Drug Intermediates 4-AA Sales by Country (2019-2024) & (Tons)
Table 32. Europe Penem Drug Intermediates 4-AA Sales by Country (2025-2030) & (Tons)
Table 33. Europe Penem Drug Intermediates 4-AA Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Penem Drug Intermediates 4-AA Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Penem Drug Intermediates 4-AA Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Penem Drug Intermediates 4-AA Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Penem Drug Intermediates 4-AA Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Penem Drug Intermediates 4-AA Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Penem Drug Intermediates 4-AA Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Penem Drug Intermediates 4-AA Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Penem Drug Intermediates 4-AA Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Penem Drug Intermediates 4-AA Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Penem Drug Intermediates 4-AA Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Penem Drug Intermediates 4-AA Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Penem Drug Intermediates 4-AA Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Penem Drug Intermediates 4-AA Sales by Country (2019-2024) & (Tons)
Table 47. Middle East and Africa Penem Drug Intermediates 4-AA Sales by Country (2025-2030) & (Tons)
Table 48. Middle East and Africa Penem Drug Intermediates 4-AA Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Penem Drug Intermediates 4-AA Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Penem Drug Intermediates 4-AA Sales (Tons) by Type (2019-2024)
Table 51. Global Penem Drug Intermediates 4-AA Sales (Tons) by Type (2025-2030)
Table 52. Global Penem Drug Intermediates 4-AA Sales Market Share by Type (2019-2024)
Table 53. Global Penem Drug Intermediates 4-AA Sales Market Share by Type (2025-2030)
Table 54. Global Penem Drug Intermediates 4-AA Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Penem Drug Intermediates 4-AA Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Penem Drug Intermediates 4-AA Revenue Market Share by Type (2019-2024)
Table 57. Global Penem Drug Intermediates 4-AA Revenue Market Share by Type (2025-2030)
Table 58. Global Penem Drug Intermediates 4-AA Price (US$/Ton) by Type (2019-2024)
Table 59. Global Penem Drug Intermediates 4-AA Price (US$/Ton) by Type (2025-2030)
Table 60. Global Penem Drug Intermediates 4-AA Sales (Tons) by Application (2019-2024)
Table 61. Global Penem Drug Intermediates 4-AA Sales (Tons) by Application (2025-2030)
Table 62. Global Penem Drug Intermediates 4-AA Sales Market Share by Application (2019-2024)
Table 63. Global Penem Drug Intermediates 4-AA Sales Market Share by Application (2025-2030)
Table 64. Global Penem Drug Intermediates 4-AA Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Penem Drug Intermediates 4-AA Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Penem Drug Intermediates 4-AA Revenue Market Share by Application (2019-2024)
Table 67. Global Penem Drug Intermediates 4-AA Revenue Market Share by Application (2025-2030)
Table 68. Global Penem Drug Intermediates 4-AA Price (US$/Ton) by Application (2019-2024)
Table 69. Global Penem Drug Intermediates 4-AA Price (US$/Ton) by Application (2025-2030)
Table 70. Zhejiang Hisoar Pharmaceutical Company Information
Table 71. Zhejiang Hisoar Pharmaceutical Description and Business Overview
Table 72. Zhejiang Hisoar Pharmaceutical Penem Drug Intermediates 4-AA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. Zhejiang Hisoar Pharmaceutical Penem Drug Intermediates 4-AA Product
Table 74. Zhejiang Hisoar Pharmaceutical Recent Developments/Updates
Table 75. Jiangxi Fushine Pharmaceutical Company Information
Table 76. Jiangxi Fushine Pharmaceutical Description and Business Overview
Table 77. Jiangxi Fushine Pharmaceutical Penem Drug Intermediates 4-AA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. Jiangxi Fushine Pharmaceutical Penem Drug Intermediates 4-AA Product
Table 79. Jiangxi Fushine Pharmaceutical Recent Developments/Updates
Table 80. Joincare Pharmaceutical Company Information
Table 81. Joincare Pharmaceutical Description and Business Overview
Table 82. Joincare Pharmaceutical Penem Drug Intermediates 4-AA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Joincare Pharmaceutical Penem Drug Intermediates 4-AA Product
Table 84. Joincare Pharmaceutical Recent Developments/Updates
Table 85. Jincheng Pharmaceutical Company Information
Table 86. Jincheng Pharmaceutical Description and Business Overview
Table 87. Jincheng Pharmaceutical Penem Drug Intermediates 4-AA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Jincheng Pharmaceutical Penem Drug Intermediates 4-AA Product
Table 89. Jincheng Pharmaceutical Recent Developments/Updates
Table 90. Zhejiang Jiuzhou Pharmaceutical Company Information
Table 91. Zhejiang Jiuzhou Pharmaceutical Description and Business Overview
Table 92. Zhejiang Jiuzhou Pharmaceutical Penem Drug Intermediates 4-AA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Zhejiang Jiuzhou Pharmaceutical Penem Drug Intermediates 4-AA Product
Table 94. Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Penem Drug Intermediates 4-AA Distributors List
Table 98. Penem Drug Intermediates 4-AA Customers List
Table 99. Penem Drug Intermediates 4-AA Market Trends
Table 100. Penem Drug Intermediates 4-AA Market Drivers
Table 101. Penem Drug Intermediates 4-AA Market Challenges
Table 102. Penem Drug Intermediates 4-AA Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Penem Drug Intermediates 4-AA
Figure 2. Global Penem Drug Intermediates 4-AA Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Penem Drug Intermediates 4-AA Market Share by Type: 2023 & 2030
Figure 4. Purity≥98% Product Picture
Figure 5. Other Product Picture
Figure 6. Global Penem Drug Intermediates 4-AA Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Penem Drug Intermediates 4-AA Market Share by Application: 2023 & 2030
Figure 8. Imipenem
Figure 9. Meropenem
Figure 10. Ertapenem
Figure 11. Biapenem
Figure 12. Other
Figure 13. Global Penem Drug Intermediates 4-AA Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Penem Drug Intermediates 4-AA Market Size (2019-2030) & (US$ Million)
Figure 15. Global Penem Drug Intermediates 4-AA Sales (2019-2030) & (Tons)
Figure 16. Global Penem Drug Intermediates 4-AA Average Price (US$/Ton) & (2019-2030)
Figure 17. Penem Drug Intermediates 4-AA Report Years Considered
Figure 18. Penem Drug Intermediates 4-AA Sales Share by Manufacturers in 2023
Figure 19. Global Penem Drug Intermediates 4-AA Revenue Share by Manufacturers in 2023
Figure 20. Global 5 and 10 Largest Penem Drug Intermediates 4-AA Players: Market Share by Revenue in Penem Drug Intermediates 4-AA in 2023
Figure 21. Penem Drug Intermediates 4-AA Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global Penem Drug Intermediates 4-AA Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Penem Drug Intermediates 4-AA Sales Market Share by Country (2019-2030)
Figure 24. North America Penem Drug Intermediates 4-AA Revenue Market Share by Country (2019-2030)
Figure 25. United States Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Penem Drug Intermediates 4-AA Sales Market Share by Country (2019-2030)
Figure 28. Europe Penem Drug Intermediates 4-AA Revenue Market Share by Country (2019-2030)
Figure 29. Germany Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Penem Drug Intermediates 4-AA Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Penem Drug Intermediates 4-AA Revenue Market Share by Region (2019-2030)
Figure 36. China Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Penem Drug Intermediates 4-AA Sales Market Share by Country (2019-2030)
Figure 44. Mexico Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East and Africa Penem Drug Intermediates 4-AA Sales Market Share by Country (2019-2030)
Figure 49. Middle East and Africa Penem Drug Intermediates 4-AA Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Penem Drug Intermediates 4-AA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Penem Drug Intermediates 4-AA by Type (2019-2030)
Figure 54. Global Revenue Market Share of Penem Drug Intermediates 4-AA by Type (2019-2030)
Figure 55. Global Penem Drug Intermediates 4-AA Price (US$/Ton) by Type (2019-2030)
Figure 56. Global Sales Market Share of Penem Drug Intermediates 4-AA by Application (2019-2030)
Figure 57. Global Revenue Market Share of Penem Drug Intermediates 4-AA by Application (2019-2030)
Figure 58. Global Penem Drug Intermediates 4-AA Price (US$/Ton) by Application (2019-2030)
Figure 59. Penem Drug Intermediates 4-AA Value Chain
Figure 60. Penem Drug Intermediates 4-AA Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
